Healthcare Providers and Services
Company Overview of Seattle Children's Hospital
Seattle Children's Hospital operates a child health care and pediatric center in the United States. The company offers adolescent gynecology, medicine, behavioral, and substance abuse programs; and ambulatory infusion, anesthesia, audiology, bioethics consultation, blood disorders, cancer, cardiac surgery, children with special needs, complex care, craniofacial center, critical care medicine, dental medicine, dialysis, eating disorders, endocrinology/diabetes, family advisory council, financial counseling, and gastroenterology services. The company also provides thoracic surgery, genetics, growth and feeding dynamics, gynecology, health information management, hematology, insurance and inter...
4800 Sand Point Way NE
Seattle, WA 98105
Founded in 1907
Key Executives for Seattle Children's Hospital
Chief Executive Officer and Trustee
Chief Financial Officer and Senior Vice President
Surgeon-In-Chief, Senior Vice President, President of CUMG, and Trustee
President of Seattle Children's Hospital Research Institute
Compensation as of Fiscal Year 2016.
Seattle Children's Hospital Key Developments
Seattle Children's T-Cell Immunotherapy Clinical Trial for Children With Relapsed Leukemia Shows 93% Complete Remission Rate
Jun 2 16
Seattle Children's announced that 39 of 42 patients treated in a Phase 1 clinical trial using genetically reprogrammed T cells to treat relapsed or refractory acute lymphoblastic leukemia (ALL) have achieved complete remission, showing no detectable leukemia cells in the most sensitive tests. Patients treated in the trial, known as Pediatric Leukemia Adoptive Therapy-02 (PLAT-02), had less than a 20% chance of survival upon enrollment using current treatments. Seattle Children's will launch Phase 2 of the trial this month, with the aim to enroll 70 patients in 2016. The PLAT-02 trial includes patients with ALL who have relapsed after a bone marrow transplant, or who are unable to get into remission to proceed with a bone marrow transplant. Using T-cell immunotherapy, the research team led by Dr. Mike Jensen at the Ben Towne Center for Childhood Cancer Research at Seattle Children's Research Institute reprograms a patient's T cells so they can hunt down and destroy cancer cells wherever they are hiding in the body. Another key finding from Phase 1 is that of the patients who achieved initial remission, about 50% are still in remission one year after therapy. For the patients that relapsed, researchers have found that their reprogrammed T cells are no longer present or the cancer has evolved to circumvent the T cells. The first phase of PLAT-02 was integral in establishing the safety of the therapy and the optimal dose of T cells. Phase 2 will demonstrate how this therapy works for a larger group of patients.
Jeff Brown Joins as Senior Vice President, CIO of Seattle Children's Hospital
Feb 1 16
Seattle Children's announced that Jeff Brown has been appointed to the position of senior vice president and chief information officer of Seattle Children's effective Feb. 1. Brown has filled the CIO role at Seattle Children's on an interim basis since April 2015. In April 2015, Brown joined Seattle Children's from Lawrence General Hospital in Lawrence, Mass., where he served as CIO. In that role, Brown focused on mobilizing healthcare information electronically across an integrated healthcare system, accountable care organization (ACO) design, as well as population health and organization-wide digital healthcare strategies.
Seattle Children's Appoints Lisa Rediger Hayward as Senior Vice President and General Counsel, Effective January 4, 2016
Nov 3 15
Seattle Children's announced that Lisa Rediger Hayward has been appointed to the position of senior vice president and general counsel of Seattle Children's effective Jan. 4, 2016. Hayward replaces Jeff Sconyers, who retired earlier 2015. Hayward, 48, is currently a partner at Davis Wright Tremaine, LLP in Seattle, where she will remain until she transitions to Seattle Children's. In that position, Hayward has worked closely with health systems, hospitals and multi-specialty medical groups on a wide range of regulatory and transactional matters. Some of her key accomplishments included assisting in the development of accountable care organizations as well as clinically integrated networks and advising health systems in Washington's certificate of need process.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|